TGFA and neoplasm: Elevated baseline levels of TGF-alpha were associated with a higher likelihood of tumor growth, despite erlotinib, on post-treatment radiographic assessment (bias adjusted Spearman's rho = 0.48, z-test p = 0.02; β = 0.50 se = 0.19, F test p = 0.02).